AGN 211745
211745-001
Phase 2 small_molecule terminated
Quick answer
AGN 211745 for Choroid Neovascularization is a Phase 2 program (small_molecule) at Allergan Pharmaceuticals International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Choroid Neovascularization
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated